Commentary: Usage of Mitogen-Activated Protein Kinase Small Molecule Inhibitors: More Than Just Inhibition!
作者信息
Pollet Marius, Krutmann Jean, Haarmann-Stemmann Thomas
机构信息
IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany.
Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.
出版信息
Front Pharmacol. 2018 Aug 20;9:935. doi: 10.3389/fphar.2018.00935. eCollection 2018.
Abstract
摘要
相似文献
1
Commentary: Usage of Mitogen-Activated Protein Kinase Small Molecule Inhibitors: More Than Just Inhibition!评论：丝裂原活化蛋白激酶小分子抑制剂的应用：不仅仅是抑制！
Front Pharmacol. 2018 Aug 20;9:935. doi: 10.3389/fphar.2018.00935. eCollection 2018.
2
Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes.丝裂原活化蛋白激酶抑制剂U0126在肝细胞中激活芳烃受体并诱导细胞色素P450 1A
Mol Pharmacol. 2004 Apr;65(4):934-43. doi: 10.1124/mol.65.4.934.
3
Usage of Mitogen-Activated Protein Kinase Small Molecule Inhibitors: More Than Just Inhibition!丝裂原活化蛋白激酶小分子抑制剂的用途：不止于抑制！
Front Pharmacol. 2018 Feb 12;9:98. doi: 10.3389/fphar.2018.00098. eCollection 2018.
4
PD98059 is an equipotent antagonist of the aryl hydrocarbon receptor and inhibitor of mitogen-activated protein kinase kinase.PD98059是芳烃受体的等效拮抗剂和丝裂原活化蛋白激酶激酶的抑制剂。
Mol Pharmacol. 1998 Mar;53(3):438-45. doi: 10.1124/mol.53.3.438.
5
Microtubules-interfering agents restrict aryl hydrocarbon receptor-mediated CYP1A2 induction in primary cultures of human hepatocytes via c-jun-N-terminal kinase and glucocorticoid receptor.微管干扰剂通过c-jun氨基末端激酶和糖皮质激素受体限制人肝细胞原代培养物中芳烃受体介导的CYP1A2诱导。
Eur J Pharmacol. 2008 Mar 10;581(3):244-54. doi: 10.1016/j.ejphar.2007.11.059. Epub 2007 Dec 3.
6
Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling.白藜芦醇通过p38丝裂原活化蛋白激酶/丝裂原和应激激活蛋白激酶1/环磷酸腺苷反应元件结合蛋白信号通路增强缺血心脏中的存活信号。
J Pharmacol Exp Ther. 2006 Jun;317(3):980-8. doi: 10.1124/jpet.105.095133. Epub 2006 Mar 8.
7
Suppression mechanisms of flavonoids on aryl hydrocarbon receptor-mediated signal transduction.黄酮类化合物对芳烃受体介导的信号转导的抑制机制。
Arch Biochem Biophys. 2010 Sep 1;501(1):134-41. doi: 10.1016/j.abb.2010.05.002. Epub 2010 May 5.
8
Analysis of Glycogen Synthase Kinase Inhibitors That Regulate Cytochrome P450 Expression in Primary Human Hepatocytes by Activation of β-Catenin, Aryl Hydrocarbon Receptor and Pregnane X Receptor Signaling.通过激活β-连环蛋白、芳烃受体和孕烷X受体信号通路来调节原代人肝细胞中细胞色素P450表达的糖原合酶激酶抑制剂分析。
Toxicol Sci. 2015 Nov;148(1):261-75. doi: 10.1093/toxsci/kfv177. Epub 2015 Aug 10.
9
Induction of UGT1A1 and CYP2B6 by an antimitogenic factor in HepG2 cells is mediated through suppression of cyclin-dependent kinase 2 activity: cell cycle-dependent expression.在 HepG2 细胞中，抗有丝分裂因子诱导 UGT1A1 和 CYP2B6 的表达是通过抑制细胞周期依赖性激酶 2 的活性介导的：细胞周期依赖性表达。
Drug Metab Dispos. 2010 Jan;38(1):177-86. doi: 10.1124/dmd.109.029785.
10
Parallel contractile signal transduction pathways activated by receptors for thrombin and epidermal growth factor-urogastrone in guinea pig gastric smooth muscle: blockade by inhibitors of mitogen-activated protein kinase-kinase and phosphatidyl inositol 3'-kinase.凝血酶和表皮生长因子-尿抑胃素受体激活的豚鼠胃平滑肌平行收缩信号转导途径：丝裂原活化蛋白激酶激酶和磷脂酰肌醇3'-激酶抑制剂的阻断作用
J Pharmacol Exp Ther. 1998 Apr;285(1):325-34.
引用本文的文献
1
Stress Activated MAP Kinases and Cyclin-Dependent Kinase 5 Mediate Nuclear Translocation of Nrf2 via Hsp90α-Pin1-Dynein Motor Transport Machinery.应激激活的丝裂原活化蛋白激酶和细胞周期蛋白依赖性激酶5通过Hsp90α-Pin1-动力蛋白运输机制介导Nrf2的核转位。
Antioxidants (Basel). 2023 Jan 26;12(2):274. doi: 10.3390/antiox12020274.
2
3
Diet-Host-Microbiota Interactions Shape Aryl Hydrocarbon Receptor Ligand Production to Modulate Intestinal Homeostasis.饮食-宿主-微生物群相互作用塑造芳香烃受体配体的产生，以调节肠道内稳态。
Annu Rev Nutr. 2021 Oct 11;41:455-478. doi: 10.1146/annurev-nutr-043020-090050.
4
Role of the Aryl Hydrocarbon Receptor in Environmentally Induced Skin Aging and Skin Carcinogenesis.芳香烃受体在环境诱导的皮肤衰老和皮肤癌变中的作用。
Int J Mol Sci. 2019 Nov 28;20(23):6005. doi: 10.3390/ijms20236005.
本文引用的文献
1
Usage of Mitogen-Activated Protein Kinase Small Molecule Inhibitors: More Than Just Inhibition!丝裂原活化蛋白激酶小分子抑制剂的用途：不止于抑制！
Front Pharmacol. 2018 Feb 12;9:98. doi: 10.3389/fphar.2018.00098. eCollection 2018.
2
Modulation of CYP1A1 metabolism: From adverse health effects to chemoprevention and therapeutic options.CYP1A1 代谢的调节：从不良健康影响到化学预防和治疗选择。
Pharmacol Ther. 2018 Jul;187:71-87. doi: 10.1016/j.pharmthera.2018.02.012. Epub 2018 Feb 17.
3
And Now for Something Completely Different: Diversity in Ligand-Dependent Activation of Ah Receptor Responses.现在来看一些完全不同的内容：芳烃受体反应的配体依赖性激活中的多样性。
Curr Opin Toxicol. 2017 Feb;2:124-131. doi: 10.1016/j.cotox.2017.01.006.
4
Non-kinase targets of protein kinase inhibitors.蛋白激酶抑制剂的非激酶靶点。
Nat Rev Drug Discov. 2017 Jun;16(6):424-440. doi: 10.1038/nrd.2016.266. Epub 2017 Mar 10.
5
FDA-approved small-molecule kinase inhibitors.美国食品和药物管理局批准的小分子激酶抑制剂。
Trends Pharmacol Sci. 2015 Jul;36(7):422-39. doi: 10.1016/j.tips.2015.04.005. Epub 2015 May 12.
6
Aryl hydrocarbon receptor ligands in cancer: friend and foe.癌症中的芳烃受体配体：亦敌亦友
Nat Rev Cancer. 2014 Dec;14(12):801-14. doi: 10.1038/nrc3846.
7
Activation of the aryl hydrocarbon receptor by the widely used Src family kinase inhibitor 4-amino-5-(4-chlorophenyl)-7-(dimethylethyl)pyrazolo[3,4-d]pyrimidine (PP2).广泛使用的Src家族激酶抑制剂4-氨基-5-（4-氯苯基）-7-（二甲基乙基）吡唑并[3,4-d]嘧啶（PP2）对芳烃受体的激活作用。
Arch Toxicol. 2015 Aug;89(8):1329-36. doi: 10.1007/s00204-014-1321-8. Epub 2014 Aug 1.
8
U0126, a mitogen-activated protein kinase kinase 1 and 2 (MEK1 and 2) inhibitor, selectively up-regulates main isoforms of CYP3A subfamily via a pregnane X receptor (PXR) in HepG2 cells.U0126，一种丝裂原活化蛋白激酶激酶 1 和 2（MEK1 和 2）抑制剂，通过 HepG2 细胞中的孕烷 X 受体（PXR）选择性地上调 CYP3A 亚家族的主要同工酶。
Arch Toxicol. 2014 Dec;88(12):2243-59. doi: 10.1007/s00204-014-1254-2. Epub 2014 May 14.
9
Sunitinib, a tyrosine kinase inhibitor, induces cytochrome P450 1A1 gene in human breast cancer MCF7 cells through ligand-independent aryl hydrocarbon receptor activation.舒尼替尼是一种酪氨酸激酶抑制剂，通过非配体依赖的芳香烃受体激活诱导人乳腺癌 MCF7 细胞细胞色素 P4501A1 基因。
Arch Toxicol. 2013 May;87(5):847-56. doi: 10.1007/s00204-012-0996-y. Epub 2013 Jan 4.
10
PXR-mediated P-glycoprotein induction by small molecule tyrosine kinase inhibitors.小分子酪氨酸激酶抑制剂介导的 PXR 诱导 P-糖蛋白表达。
Eur J Pharm Sci. 2013 Mar 12;48(4-5):644-9. doi: 10.1016/j.ejps.2012.12.019. Epub 2012 Dec 28.
Zotero 插件